TABLE 1.
Tolerant and intolerant residues from RGS domains of interest that also overlap with highly deleterious somatic mutations were selected for assessment of their impact on RGS functions. Amino acids reported in the COSMIC cancer database were selected based on the criteria that were predicted to be pathogenic by the FATHMM score to be highly pathogenic. Scores above 0.5 are deleterious; scores ≥0.7 are classified as pathogenic.
| Pathogenic Score | Cancer Type | 3DMTR (Score) | |
|---|---|---|---|
| RGS14 | |||
| S127P | 0.91 | Stomach Carcinoma | Tolerant (1.03) |
| D137Y | 0.97 | Prostate Carcinoma | Tolerant (0.93) |
| R173C | 0.81 | Large Intestine Carcinoma | Intolerant (0.50) |
| R173H | 0.97 | Large Intestine Carcinoma | Intolerant (0.50) |
| RGS10 | |||
| S64T | 0.96 | Lung Carcinoma | Tolerant (0.91) |
| K89M | 0.84 | Thyroid Carcinoma | Intolerant (0.48) |
| RGS4 | |||
| K125Q | 0.97 | Lung Adenocarcinoma | Intolerant (0.48) |
| E126K | 1.00 | Skin Melanoma | Intolerant (0.42) |
| E135K | 1.00 | Skin Carcinoma, Melanoma, Upper Aerodigestive Tract Carcinoma | Tolerant (1.14) |